Louis M. Solomon is a partner in Haynes and Boone's New York Litigation Practice. He has extensive experience litigating complex business, commercial, securities and bankruptcy and business restructuring cases.
Mr. Solomon represents clients in various complex commercial matters, including securities fraud cases, breach of contract actions, and partnership disputes. Mr. Solomon has represented individuals and corporations in connection with government and internal investigations, and has litigated numerous fraud cases involving banks and brokerages. Mr. Solomon's practice has also included real property actions involving senior and subordinated debt, and a variety of intellectual property matters. Mr. Solomon also has extensive experience in arbitration and mediations before various tribunals, including the AAA, the ICC and the ICDR.
Mr. Solomon is the co-author of the section on trademark infringement appearing in Business and Commercial Litigation in Federal Courts (West 2009). He was named as a New York Super Lawyer in Business Litigation, 2012-2014. He has also lectured on developments in hedge fund oversight.
Mr. Solomon has:
- Represented clients in multi-million dollar litigations involving:
- Securities fraud claims
- Advance fee fraud claims
- Prime bank fraud claims
- Dissolution of partnerships
- Claims by lenders against borrowers and guarantors
- Claims arising out of securitized transactions
- Credit default and swap transactions
- Distributorship agreements
- Generic pharmaceuticals
- Trademark infringement
- Antitrust claims on behalf of a trade association
- Insider trading claims
- Claims in bankruptcy proceedings
- Estate proceedings
- Conducted internal investigations for publicly traded companies
- Conducted numerous arbitrations before the AAA, ICC, and ICDR
Selected Representative Experience
Multi-Billion Dollar Pharmaceutical Sale
Served as U.S. counsel to Strides Arcolab Ltd. in its $1.6 billion sale of Agila Specialties Private Ltd., a generic drug maker of injectable medicines, to Mylan Inc., the second largest stand-alone generic drug maker in the world.
FKF Madison Park Group Owner, LLC Chapter 11
Represented a joint venture, in which the managing member was one of the nation's top real estate development firms, in the acquisition through the bankruptcy process of the debtors' equity in a luxury Manhattan condominium project where secured debt alone is approximately $250 million. Assisted with and coordinated all aspects of the joint venture's efforts, including development of strategy, negotiations with adverse parties, and handling all of the joint venture's transactional, bankruptcy and litigation requirements.